Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A humble aquarium fish may hold the key to new therapies for birth defects

09.08.2006
A humble aquarium fish may hold the key to finding therapies capable of preventing the structural birth defects that account for one out of three infant deaths in the United States today.

That is one of the implications of a new study published online August 8 in the journal Cell Metabolism. The paper describes a number of striking parallels between a rare but fatal human birth defect called Menkes disease and a lethal mutation in a small tropical fish called the zebrafish that has become an important animal model for studying early development.

Zebrafish are easy and inexpensive to raise and lay eggs that are transparent and develop outside the body. Much of the zebrafish genome has been sequenced, allowing researchers to identify human versions of zebrafish genes and vice versa. These qualities make the zebrafish exceptionally handy in studying the complex relationship between genes and nutrition during development, a puzzle that has stood in the way of developing effective treatments for birth defects.

“This is a proof of concept that we can use the zebrafish to finally understand the role that maternal nutrition plays in causing structural birth defects and develop new treatments that can prevent them,” said co-author Jonathan Gitlin, the Helene B. Robertson Professor of Pediatrics at Washington University in Saint Louis. Collaborating in the study were Professor of Biological Sciences Lilianna Solnica-Krezel, postdoctoral fellow Thomas P. Wilm and graduate student Chunyue Yin from Vanderbilt University along with Associate Professor of Genetics Stephen L. Johnson and graduate student Bryce A. Mendelsohn from Washington University in St. Louis.

For many years, scientists have relied on the mouse and the frog Xenopus laevis as research models for vertebrates (animals with backbones), but zebrafish have an important advantage for studying early development: It is possible for researchers to watch the changes that take place in their embryos from the moment of fertilization. The small fish have another advantage for studying the role of nutrition: Scientists can precisely regulate the nutrients that the embryo receives largely free from maternal influence.

In the paper, the researchers describe the discovery of a mutation in the zebrafish that disrupts the distribution of the critical nutrient copper within the fish cells and causes defects that are remarkably similar to those observed in children suffering from Menkes kinky hair disease, which, in its most severe form, causes degeneration and death within two to three years after birth.

“We found this mutation about two and a half years ago,” said Solnica-Krezel. “Because it impairs so many aspects of normal development and causes the embryo to fall apart in two days, we named it ‘Calamity.’” Six months later, she heard a talk that Gitlin gave at a scientific meeting about the results of exposing zebrafish embryos to a chemical agent that disrupts copper metabolism. She was struck by the similarity between his results and those produced by Calamity, so she approached him and they decided to collaborate.

“Lila and the other zebrafish geneticists have created all these wonderful tools,” said Gitlin. “I feel like a cook that walks into this wonderfully equipped kitchen and realizes there all these wonderful recipes that he can prepare!”

The researchers explored the effect on embryo development of varying the amount of copper available and disabling different pieces of the molecular mechanisms that cells use to handle this potentially toxic material. The consequences were quite dramatic because copper-containing enzymes play a number of critical roles in the life of the cell. They are involved in the process by which a cell burns sugars and disposes of the carbon dioxide and water byproducts. They are required to produce pigmentation and develop connective tissue. These “cuproenzymes” are also necessary for creating the neurotransmitters essential for brain function.

The researchers discovered that the Calamity mutation occurs in a gene that codes for a key copper distribution enzyme, labeled Apt7a. This is a very large and complicated protein that sits in a cell structure called the Golgi complex, which manufactures a large variety of enzymes that function both inside and outside of the cell. Apt7a also extends outside of the cell and its primary function is to bring copper atoms into the cell and transport them to the Golgi for incorporation into various enzymes. They have determined that the Calamity mutation occurs in a location that totally inactivates the enzyme.

To determine whether the disruption in copper distribution was confined to individual cells, the researchers inserted normal cells into calamity embryos. The fact that the “wild-type” cells functioned normally helped to explain why attempts to treat Menkes with copper supplements has only proven beneficial in the milder versions of the disease. It showed that the problem was not lack of copper per se, but an inability of cells to import the copper that they need to produce key enzymes.

Next, the scientists established that the zebrafish gene is a close cousin of the human Menkes gene. They injected the human Menkes enzyme into Calamity embryos and found that it works almost as well as the fish enzyme and rescues embryos from a number of the mutant’s defects.

That demonstrated just how similar the molecular mechanisms for handling copper are in the zebrafish and in humans. This didn’t come as a big surprise because the researchers know that evolution tends to be highly conservative. That is, when nature finds an effective way to accomplish a life-critical operation, it tends to keep using it. Handling metal atoms like copper is one such operation. These atoms are essential but can be very destructive if they get loose within the cell.

“The fact that injecting the human gene can rescue the zebrafish embryo is also an example of gene therapy that works really well, at least temporarily in the fish,” adds Solnica-Krezel.

The zebrafish also makes it possible to pursue another, even more promising approach for developing a treatment for Menkes: Testing hundreds or thousands of compounds to see if any can restore proper copper-handling in Calamity mutants. If such a drug can be found, it would be a strong candidate for treating the disorder in human embryos.

“The zebrafish is the first animal model that allows us to watch the process of early vertebrate development and manipulate it. There is no reason why the same approach that we have used with copper cannot work for other nutrients as well,” said Gitlin.

In fact, applying this approach to other nutrients and other types of birth defects is the goal of the Children’s Discovery Institute, a major new initiative that Gitlin is heading as a joint venture between the St. Louis Children’s Hospital and Washington University.

This research was funded by grants from the National Institutes of Health.

David F. Salisbury | Vanderbilt University
Further information:
http://www.vanderbilt.edu
http://www.vanderbilt.edu/exploration/stories/calamity.html

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>